Loading...
Comparative Immunogenicity and Efficacy of Thermostable (Lyophilized) and Liquid Formulation of Anthrax Vaccine Candidate AV7909
The anthrax vaccine candidate AV7909 is being developed as a next-generation vaccine for a post-exposure prophylaxis (PEP) indication against anthrax. AV7909 consists of the anthrax vaccine adsorbed (AVA) (Emergent BioSolutions Inc., Lansing, MI) bulk drug substance adjuvanted with the immunostimula...
Na minha lista:
| Udgivet i: | Vaccine |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764848/ https://ncbi.nlm.nih.gov/pubmed/31530467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.09.015 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|